Governments are racing to build AI smarter than humans. Experts warn the first to reach AGI could reshape global ...

Tech pioneers Dave Copps and Taylor Shead explain how artificial intelligence is transforming the way companies operate, ...

Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.

In a group of Chinese patients with normal low-density lipoprotein cholesterol (LDL-c), serum albumin to creatinine (sACR) showed an inverse and non-linear relationship with the risk of non-alcoholic ...

Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction 1. In patients with heart failure with preserved ejection fraction (HFpEF), β-blocker use was not ...

Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech company focused on artificial intelligence (AI), went public in April ...

In July 2025, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) expanded its rare disease pipeline by acquiring REV102, an oral ...

Recursion Pharmaceuticals, Inc. ( NASDAQ: RXRX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common stock. Chief R&D and commercial officer Najit Khan was also a seller; she ...

IIT Guwahati has released the GATE 2026 Syllabus for Computer Science & Information Technology (CS&IT) along with the ...